Advertisement
Coronary Artery Disease| Volume 117, ISSUE 3, P359-365, February 01, 2016

Download started.

Ok

Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures

Published:November 17, 2015DOI:https://doi.org/10.1016/j.amjcard.2015.10.056
      In this study, we aim to assess whether remote ischemic preconditioning (RIPC) reduces platelet activation during coronary angiography (CA) and/or percutaneous coronary interventions. We studied 30 patients who underwent CA because of a suspect of stable angina. Patients were randomized to RIPC (3 short episodes of forearm ischemia) or sham RIPC (controls) before the procedure. Blood samples were collected at baseline, at the end of the procedure, and 24 hours later. Monocyte–platelet aggregate (MPA) formation and platelet CD41 in the MPA gate and CD41 and CD62 expression in the platelet gate were assessed by flow cytometry, in the absence and in the presence of adenosine diphosphate (ADP) stimulation. A significant increase in platelet activation occurred during the invasive procedure in controls, which persisted at 24 hours. However, compared with controls, RIPC group showed no or a lower increase in platelet variables, including MPA formation (p <0.0001) and CD41 (p = 0.002) in the MPA gate and CD41 (p <0.0001) and CD62 (p = 0.002) in the platelet gate. ADP increased platelet activation at baseline, but did not further increase platelet reactivity during the invasive procedure in either groups. Percutaneous coronary interventions, performed in 10 patients (6 in the RIPC group and 4 in controls), did not have any further significant effect on platelet activation and reactivity compared with CA alone. In conclusion, RIPC reduces platelet activation occurring during CA. In contrast, no effects were observed on platelet response to ADP stimulation, probably related to the administration of an ADP antagonist in all patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Iakovou I.
        • Schmidt T.
        • Bonizzoni E.
        • Ge L.
        • Sangiorgi G.M.
        • Stankovic G.
        • Airoldi F.
        • Chieffo A.
        • Montorfano M.
        • Carlino M.
        • Michev I.
        • Corvaja N.
        • Briguori C.
        • Gerckens U.
        • Grube E.
        • Colombo A.
        Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
        JAMA. 2005; 293: 2126-2130
        • Mangiacapra F.
        • Bartunek J.
        • Bijnens N.
        • Peace A.J.
        • Dierickx K.
        • Bailleul E.
        • Di Serafino L.
        • Pyxaras S.A.
        • Fraeyman A.
        • Meeus P.
        • Rutten M.
        • De Bruyne B.
        • Wijns W.
        • van de Vosse F.
        • Barbato E.
        Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention.
        J Thromb Haemost. 2012; 10: 2452-2461
        • Mickelson J.K.
        • Lakkis N.M.
        • Villarreal-Levy G.
        • Hughes B.J.
        • Smith C.W.
        Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?.
        J Am Coll Cardiol. 1996; 28: 345-353
        • Kolarov P.
        • Tschoepe D.
        • Nieuwenhuis H.K.
        • Gries F.A.
        • Strauer B.
        • Schultheiss H.P.
        PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS).
        Eur Heart J. 1996; 17: 1216-1222
        • Serrano Jr., C.V.
        • Ramires J.A.
        • Venturinelli M.
        • Arie S.
        • D'Amico E.
        • Zweier J.L.
        • Pileggi F.
        • da Luz P.L.
        Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty.
        J Am Coll Cardiol. 1997; 29: 1276-1283
        • Warzok F.
        • Steiner M.
        • Blann A.D.
        • Weber F.
        • Urbaszek W.
        • Schuff-Werner P.
        Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease.
        Blood Coagul Fibrinolysis. 1999; 10: 381-387
        • Hay K.L.
        • Bull B.S.
        An analysis of platelet activation and aggregation produced by three classes of contrast media.
        J Vasc Interv Radiol. 1995; 6: 211-217
        • Chronos N.A.
        • Goodall A.H.
        • Wilson D.J.
        • Sigwart U.
        • Buller N.P.
        Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology.
        Circulation. 1993; 88: 2035-2044
        • Kharbanda R.K.
        • Mortensen U.M.
        • White P.A.
        • Kristiansen S.B.
        • Schmidt M.R.
        • Hoschtitzky J.A.
        • Vogel M.
        • Sorensen K.
        • Redington A.N.
        • MacAllister R.
        Transient limb ischemia induces remote ischemic preconditioning in vivo.
        Circulation. 2002; 106: 2881-2883
        • Heusch G.
        • Bøtker H.E.
        • Przyklenk K.
        • Redington A.
        • Yellon D.
        Remote ischemic conditioning.
        J Am Coll Cardiol. 2015; 65: 177-195
        • Battipaglia I.
        • Scalone G.
        • Milo M.
        • Di Franco A.
        • Lanza G.A.
        • Crea F.
        Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease.
        Heart. 2011; 97: 1298-1303
        • Stazi A.
        • Scalone G.
        • Laurito M.
        • Milo M.
        • Pelargonio G.
        • Narducci M.L.
        • Parrinello R.
        • Figliozzi S.
        • Bencardino G.
        • Perna F.
        • Lanza G.A.
        • Crea F.
        Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation.
        Circulation. 2014; 129: 11-17
        • Aurigemma C.
        • Fattorossi A.
        • Sestito A.
        • Sgueglia G.A.
        • Farnetti S.
        • Buzzonetti A.
        • Infusino F.
        • Landolfi R.
        • Scambia G.
        • Crea F.
        • Lanza G.A.
        Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
        Thromb Res. 2007; 120: 901-909
        • Scharf R.E.
        • Tomer A.
        • Marzec U.M.
        • Teirstein P.S.
        • Ruggeri Z.M.
        • Harker L.A.
        Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection.
        Arterioscler Thromb. 1992; 12: 1475-1487
        • Inoue T.
        • Komoda H.
        • Kotooka N.
        • Morooka T.
        • Fujimatsu D.
        • Hikichi Y.
        • Soma R.
        • Uchida T.
        • Node K.
        Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation.
        Atherosclerosis. 2008; 196: 469-476
        • Scalone G.
        • Coviello I.
        • Barone L.
        • Pisanello C.
        • Sestito A.
        • Lanza G.A.
        • Crea F.
        Brief low-workload myocardial ischaemia induces protection against exercise-related increase of platelet reactivity in patients with coronary artery disease.
        Heart. 2010; 96: 263-268
        • Bøtker H.E.
        • Kharbanda R.
        • Schmidt M.R.
        • Bøttcher M.
        • Kaltoft A.K.
        • Terkelsen C.J.
        • Munk K.
        • Andersen N.H.
        • Hansen T.M.
        • Trautner S.
        • Lassen J.F.
        • Christiansen E.H.
        • Krusell L.R.
        • Kristensen S.D.
        • Thuesen L.
        • Nielsen S.S.
        • Rehling M.
        • Sørensen H.T.
        • Redington A.N.
        • Nielsen T.T.
        Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.
        Lancet. 2010; 375: 727-734
        • Tomai F.
        • Crea F.
        • Chiariello L.
        • Gioffrè P.A.
        Ischemic preconditioning in humans: models, mediators, and clinical relevance.
        Circulation. 1999; 100: 559-563
        • Murry C.E.
        • Jennings R.B.
        • Reimer K.A.
        Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
        Circulation. 1986; 74: 1124-1136
        • Linden M.D.
        • Whittaker P.
        • Frelinger 3rd, A.L.
        • Barnard M.R.
        • Michelson A.D.
        • Przyklenk K.
        Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation.
        J Thromb Haemost. 2006; 4: 2670-2677
        • Posa A.
        • Pavo N.
        • Hemetsberger R.
        • Csonka C.
        • Csont T.
        • Ferdinandy P.
        • Petrási Z.
        • Varga C.
        • Pavo I.J.
        • Laszlo Jr., F.
        • Huber K.
        • Gyöngyösi M.
        Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs.
        Thromb Haemost. 2010; 103: 450-460
        • Pedersen C.M.
        • Cruden N.L.
        • Schmidt M.R.
        • Lau C.
        • Bøtker H.E.
        • Kharbanda R.K.
        • Newby D.E.
        Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans.
        J Thromb Haemost. 2011; 9: 404-407
        • Laskey W.K.
        • Yancy C.W.
        • Maisel W.H.
        Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health.
        Circulation. 2007; 115: 2352-2357
        • Eisenstein E.L.
        • Anstrom K.J.
        • Kong D.F.
        • Shaw L.K.
        • Tuttle R.H.
        • Mark D.B.
        • Kramer J.M.
        • Harrington R.A.
        • Matchar D.B.
        • Kandzari D.E.
        • Peterson E.D.
        • Schulman K.A.
        • Califf R.M.
        Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
        JAMA. 2007; 297: 159-168
        • Patti G.
        • Nusca A.
        • Mangiacapra F.
        • Gatto L.
        • D'Ambrosio A.
        • Di Sciascio G.
        Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
        J Am Coll Cardiol. 2008; 52: 1128-1133
        • Ben-Dor I.
        • Kleiman N.S.
        • Lev E.
        Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
        Am J Cardiol. 2009; 104: 227-233